BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8202725)

  • 1. The relationship of erythropoietin and iron metabolism to red blood cell production in humans.
    Adamson JW
    Semin Oncol; 1994 Apr; 21(2 Suppl 3):9-15. PubMed ID: 8202725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin, iron metabolism, and red blood cell production.
    Adamson J
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):5-7; discussion 8-9. PubMed ID: 8723573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cadmium on in vitro and in vivo erythropoiesis: erythroid progenitor cells (CFU-E), iron, and erythropoietin in cadmium-induced iron deficiency anemia.
    Sakata S; Iwami K; Enoki Y; Kohzuki H; Shimizu S; Matsuda M; Moriyama T
    Exp Hematol; 1988 Aug; 16(7):581-7. PubMed ID: 3391251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J; Gregora E; Lachmanová J; Brabec V
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of erythropoietin action.
    Koury MJ; Bondurant MC
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):20-3. PubMed ID: 1656733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoiesis in patients stimulated with erythropoietin: the relevance of storage iron.
    Goodnough LT; Marcus RE
    Vox Sang; 1998; 75(2):128-33. PubMed ID: 9784666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitivity of in vitro erythropoietic progenitor cells to different erythropoietin reagents during development and the role of cell death in culture.
    Zimmermann F; Rich IN
    Exp Hematol; 1996 Feb; 24(2):330-9. PubMed ID: 8641362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin: biology and clinical use.
    Graber SE; Krantz SB
    Hematol Oncol Clin North Am; 1989 Sep; 3(3):369-400. PubMed ID: 2561121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
    Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
    Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy.
    Bovy C; Baudoux E; Salmon JP; Beguin Y
    Transfusion; 2006 Sep; 46(9):1616-23. PubMed ID: 16965592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of red blood cell production.
    Adamson JW
    Am J Med; 1996 Aug; 101(2A):4S-6S. PubMed ID: 8831423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure.
    Tomson CR; Edmunds ME; Chambers K; Bricknell S; Feehally J; Walls J
    Nephrol Dial Transplant; 1992; 7(8):817-21. PubMed ID: 1325614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy.
    Goodnough LT
    Nephrol Dial Transplant; 2002; 17 Suppl 5():14-8. PubMed ID: 12091601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral erythropoietin and iron stimulate erythropoiesis in suckling rats.
    Kling PJ; Willeitner A; Dvorak B; Blohowiak SE
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):202-7. PubMed ID: 18223381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
    Beguin Y
    Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
    Tsuchiya K; Saito M; Okano-Sugiyama H; Nihei H; Ando M; Teramura M; Iwamoto YS; Shimada K; Akiba T
    Ren Fail; 2005; 27(1):59-65. PubMed ID: 15717636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.